These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9925648

  • 1. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content.
    Khoo C, Campos H, Judge H, Sacks FM.
    J Lipid Res; 1999 Feb; 40(2):202-12. PubMed ID: 9925648
    [Abstract] [Full Text] [Related]

  • 2. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.
    Campos H, Perlov D, Khoo C, Sacks FM.
    J Lipid Res; 2001 Aug; 42(8):1239-49. PubMed ID: 11483625
    [Abstract] [Full Text] [Related]

  • 3. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
    Tam SP, Dory L, Rubinstein D.
    J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.
    Zheng C, Khoo C, Furtado J, Sacks FM.
    Circulation; 2010 Apr 20; 121(15):1722-34. PubMed ID: 20368524
    [Abstract] [Full Text] [Related]

  • 5. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE, Barrett PH, Demant T, Parhofer KG.
    Nutr Metab Cardiovasc Dis; 2006 Apr 20; 16(3):215-21. PubMed ID: 16580589
    [Abstract] [Full Text] [Related]

  • 6. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA, Innis-Whitehouse W, Li X, Bakker-Arkema R, Black D, Brown WV.
    Metabolism; 2000 Feb 20; 49(2):167-77. PubMed ID: 10690940
    [Abstract] [Full Text] [Related]

  • 7. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
    Breyer ED, Le NA, Li X, Martinson D, Brown WV.
    J Lipid Res; 1999 Oct 20; 40(10):1875-82. PubMed ID: 10508207
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients.
    Marcoux C, Tremblay M, Nakajima K, Davignon J, Cohn JS.
    J Lipid Res; 1999 Apr 20; 40(4):636-47. PubMed ID: 10191287
    [Abstract] [Full Text] [Related]

  • 15. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
    Batal R, Tremblay M, Barrett PH, Jacques H, Fredenrich A, Mamer O, Davignon J, Cohn JS.
    J Lipid Res; 2000 May 20; 41(5):706-18. PubMed ID: 10787431
    [Abstract] [Full Text] [Related]

  • 16. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde.
    Luc G, Fievet C, Arveiler D, Evans AE, Bard JM, Cambien F, Fruchart JC, Ducimetiere P.
    J Lipid Res; 1996 Mar 20; 37(3):508-17. PubMed ID: 8728314
    [Abstract] [Full Text] [Related]

  • 17. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.
    Zheng C, Khoo C, Ikewaki K, Sacks FM.
    J Lipid Res; 2007 May 20; 48(5):1190-203. PubMed ID: 17314277
    [Abstract] [Full Text] [Related]

  • 18. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.
    Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, Kotite L, Kunitake ST, Havel RJ, Kane JP.
    Arterioscler Thromb; 1994 Nov 20; 14(11):1767-74. PubMed ID: 7947602
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.
    Sehayek E, Eisenberg S.
    J Biol Chem; 1991 Sep 25; 266(27):18259-67. PubMed ID: 1917954
    [Abstract] [Full Text] [Related]

  • 20. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
    Walsh BW, Sacks FM.
    J Clin Invest; 1993 May 25; 91(5):2126-32. PubMed ID: 8486779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.